Echoplanar magnetic resonance imaging (EPI) enables rapid, non-invasive ima
ging and analysis of cerebral pathophysiology in acute stroke. It represent
s an important clinical advance over computed tomography (CT) and conventio
nal magnetic resonance (MR) scanning. It can rapidly delineate infarcted ce
rebral tissue and distinguish acute from chronic stroke. In addition, EPI h
as the potential to quickly determine the presence and degree of potentiall
y viable brain tissue in the ischaemic penumbra. Thrombolysis is thought to
reperfuse the penumbra and hence reduce infarct size. The thrombolytic age
nt tissue plasminogen activator (t-PA) improves outcome in ischaemic stroke
when administered within the first 3 hours of onset. However, there is a s
ignificant risk of haemorrhage, and the time window for benefit may well ex
ceed 3 hours in some patients. Hence, by facilitating diagnosis of 'at-risk
' tissue in the ischaemic penumbra, a major clinical role of EPI may well b
ecome the rational selection of patients for acute interventional stroke th
erapy. (C) 2000 Harcourt Publishers Ltd.